Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Total Valuation
CRBP has a market cap or net worth of $441.50 million. The enterprise value is $440.81 million.
Market Cap | 441.50M |
Enterprise Value | 440.81M |
Important Dates
The last earnings date was Tuesday, March 12, 2024, before market open.
Earnings Date | Mar 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CRBP has 10.49 million shares outstanding. The number of shares has increased by 3.76% in one year.
Shares Outstanding | 10.49M |
Shares Change (YoY) | +3.76% |
Shares Change (QoQ) | +0.03% |
Owned by Insiders (%) | 1.76% |
Owned by Institutions (%) | 56.68% |
Float | 6.76M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.74
Current Ratio | 0.74 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -14.25 |
Financial Efficiency
Return on equity (ROE) is -920.30% and return on invested capital (ROIC) is -322.45%.
Return on Equity (ROE) | -920.30% |
Return on Assets (ROA) | -111.60% |
Return on Capital (ROIC) | -322.45% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.35M |
Employee Count | 33 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +502.32% in the last 52 weeks. The beta is 2.43, so CRBP's price volatility has been higher than the market average.
Beta (1Y) | 2.43 |
52-Week Price Change | +502.32% |
50-Day Moving Average | 23.68 |
200-Day Moving Average | 10.78 |
Relative Strength Index (RSI) | 61.60 |
Average Volume (30 Days) | 930,245 |
Short Selling Information
The latest short interest is 61,062, so 0.58% of the outstanding shares have been sold short.
Short Interest | 61,062 |
Short Previous Month | 92,903 |
Short % of Shares Out | 0.58% |
Short % of Float | 0.90% |
Short Ratio (days to cover) | 0.09 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -45.08M |
Pretax Income | -44.60M |
Net Income | -44.60M |
EBITDA | -41.04M |
EBIT | -41.68M |
Earnings Per Share (EPS) | -$10.31 |
Balance Sheet
The company has $21.58 million in cash and $20.88 million in debt, giving a net cash position of $691,674 or $0.07 per share.
Cash & Cash Equivalents | 21.58M |
Total Debt | 20.88M |
Net Cash | 691,674 |
Net Cash Per Share | $0.07 |
Equity / Book Value | -6.90M |
Book Value Per Share | -0.66 |
Working Capital | -8.35M |
Cash Flow
Operating Cash Flow | -36.10M |
Capital Expenditures | n/a |
Free Cash Flow | -36.10M |
FCF Per Share | -$8.34 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CRBP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.76% |
Shareholder Yield | -3.76% |
Earnings Yield | -10.10% |
FCF Yield | -8.18% |
Analyst Forecast
The average price target for CRBP is $52.00, which is 24.94% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $52.00 |
Price Target Difference | 24.94% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 14, 2023. It was a reverse split with a ratio of 1:30.
Last Split Date | Feb 14, 2023 |
Split Type | Reverse |
Split Ratio | 1:30 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |